sales forecasting

Alzheimers memory brain

Pharma

Amid launch hurdles, Eisai updates Leqembi's sales forecast

Eisai has big hopes for its amyloid-busting antibody, Leqembi, despite the slower-than-expected first phase of the launch.

Fraiser Kansteiner Mar 7, 2024 11:29am

COVID-19 vaccine

Analysts expect an autumn rebound after COVID vax sales slump

Apr 21, 2022 4:03pm